APA

Schad C., Baum U., Frank B., Dietzel U., Mattern F., Gomes C., Ponte-Sucre A., Moll H., Schurigt U. & Schirmeister T. (20161213). Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases. : Antimicrobial agents and chemotherapy.

Chicago

Schad Caroline, Baum Ulrike, Frank Benjamin, Dietzel Uwe, Mattern Felix, Gomes Carlos, Ponte-Sucre Alicia, Moll Heidrun, Schurigt Uta and Schirmeister Tanja. 20161213. Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases. : Antimicrobial agents and chemotherapy.

Harvard

Schad C., Baum U., Frank B., Dietzel U., Mattern F., Gomes C., Ponte-Sucre A., Moll H., Schurigt U. and Schirmeister T. (20161213). Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases. : Antimicrobial agents and chemotherapy.

MLA

Schad Caroline, Baum Ulrike, Frank Benjamin, Dietzel Uwe, Mattern Felix, Gomes Carlos, Ponte-Sucre Alicia, Moll Heidrun, Schurigt Uta and Schirmeister Tanja. Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases. : Antimicrobial agents and chemotherapy. 20161213.